Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment!
Does Drinking Chinese Medicine Make You Fat?
The Frontier Drug INT230-6 Has Shown Promising Therapeutic Results In Soft Tissue Sarcoma!
More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy!
Car-T Therapy Ide-Cel For Multiple Myeloma Prolongs Patient Survival By 2-Fold!
New York Presbyterian University Hospital of Columbia and Cornell
